The already intensely heated pharmaceutical and medical investment market has grown even more competitive over the past year thanks to rising interest amid the Covid-19 pandemic. Consolidation within the market has also seen the bar for entry for investors rise considerably, with even the biggest private equity firms having to fight for deals at the right size and price. Amid this febrile environment, specialist investor Revival Healthcare’s president and chairman explained to AltAssets how finding their own gap in the market led to a booming second fund close.
The post How Revival Healthcare turned belief in a brand new niche into a $500m sophomore fund first appeared on AltAssets Private Equity News.
